Leyden Labs

Leyden Labs, a biotechnology startup based in The Netherlands, has a mission to free humanity from the burden of respiratory viruses. With the slogan "Freeing humanity from the burden of respiratory viruses," the company aims to leverage its platform to combat known and future viruses. Its portfolio includes intranasal product candidates designed to protect individuals from various respiratory viruses, including those in the influenza and coronavirus families. Founded in 2020, Leyden Labs boasts a team of experienced biotechnology veterans and fresh talent committed to revolutionizing virus protection. The company recently received a significant boost with a $70.00M Series B investment on 09 January 2025. Notable investors in this round include Casdin Capital, GV, Polaris Partners, Qiming Venture Partners, and ClavystBio. Leyden Labs' focus on health and wellness, biotechnology, and life sciences positions it as a promising player in the fight against respiratory viruses. However, it's worth noting the company's vigilance against fraudulent activities, as it has cautioned individuals to verify job openings directly through their official channels to mitigate potential scams.